Innovations in Infection Management by Biocomposites
Biocomposites is making notable strides in infection management, especially when it comes to complex periprosthetic joint infections (PJI). As a Platinum Sponsor at a prestigious medical conference, they plan to showcase their expertise and cutting-edge solutions designed to improve patient outcomes.
Insights from Industry Experts on Infection Management
At the upcoming Biocomposites-sponsored symposium, leading professionals from the industry will gather to explore strategies for enhancing outcomes in complicated PJI cases. Renowned speakers, including Consultant Orthopaedic Surgeons, will delve into the best practices for infection management and the refinement of intraoperative protocols essential for dealing with difficult infections. This symposium promises to equip attendees with practical knowledge that could significantly enhance patient care.
Noteworthy Research on Antifungal Beads
One compelling abstract presented by Biocomposites researchers highlights the effectiveness of calcium sulfate beads infused with antifungal agents. These beads show promise in inhibiting the growth of drug-resistant strains of Candida auris. This research marks a significant advancement in tackling serious fungal threats that complicate infection management, potentially transforming the treatment landscape for these challenging infections.
STIMULAN®: A Revolutionary Approach to Infection Management
Biocomposites takes pride in promoting STIMULAN®, their flagship product used by surgeons worldwide as part of comprehensive infection management strategies. What sets STIMULAN® apart is its capacity to release high doses of antibiotics directly at the infection site, optimizing treatment while minimizing harm to the patient's overall health. This targeted delivery method results in lower rates of reinfection, fewer hospital readmissions, and significantly improved patient outcomes.
Pioneering Surgical Innovations
With over 100,000 cases managed each year in thousands of hospitals around the world, STIMULAN® is the sole calcium matrix antibiotic carrier approved in more than 60 countries. Biocomposites is committed to advancing surgical innovations in infection management and continues to invest in research-driven improvements.
Symposium Information and Highlights
The symposium, titled "Improving Outcomes in Complex PJI Cases," will be led by Mr. Pedro Foguet, a Consultant Orthopaedic & Trauma Surgeon. Senior Consultants will join him to share vital insights into infection management techniques. They will address topics such as the aggregation of marginal gains in treating PJI and enhancements in intraoperative protocols.
Poster Presentations and Key Findings
In addition, Biocomposites will display a significant poster exploring whether calcium sulfate beads loaded with antifungal agents can combat drug-resistant strains of Candida auris in laboratory tests. The findings from this research might lead to innovative methods for addressing these emerging infections.
All About Biocomposites
Biocomposites is a global leader in medical devices, focused on developing and marketing cutting-edge products aimed at infection management in bone and soft tissue. Headquartered in Keele, the company operates on an international scale, providing innovative solutions across various specialties, including orthopaedics and trauma care. Biocomposites' pioneering calcium compounds are essential in surgical operations around the world, with products employed in over a million procedures each year.
Frequently Asked Questions
What is the main purpose of the Biocomposites symposium?
The Biocomposites symposium aims to improve outcomes for complex periprosthetic joint infections by sharing expert insights and refining infection management strategies.
What groundbreaking research is Biocomposites presenting?
Biocomposites will showcase research on the effectiveness of calcium sulfate beads infused with antifungal agents against drug-resistant Candida auris strains, demonstrating their potential in infection management.
How does STIMULAN® enhance infection management efforts?
STIMULAN® allows surgeons to apply antibiotics directly at the site of infection, which has led to lower reinfection rates and better patient outcomes compared to systemic treatments.
Who are the featured speakers at the symposium?
Key presentations will be made by Mr. Pedro Foguet along with other prominent orthopaedic surgeons who will share their knowledge on effective infection management practices.
What is Biocomposites' goal for global healthcare?
Biocomposites aims to elevate global healthcare by providing advanced infection management solutions that ensure high-quality patient care and improved surgical outcomes worldwide.
